Get the Stockscreener App
28.24
0.20%
0.056
Elevance Health Inc stock is traded at $28.24, with a volume of 26,222.
It is up +0.20% in the last 24 hours and down -2.59% over the past month.
See More
Previous Close:
$28.18
Open:
$28.24
24h Volume:
26,222
Relative Volume:
0.36
Market Cap:
$393.95M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+0.82%
1M Performance:
-2.59%
6M Performance:
-3.52%
1Y Performance:
+6.73%
1-Day Range:
$0.00
$0.00
1-Week Range:
$27.82
$28.28
52-Week Range:
$26.28
$29.97
Elevance Health Inc Stock (EELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
404-892-0896
Address
1331 SPRING STREET NW, ATLANTA
Compare EELV vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EELV
Elevance Health Inc
|
28.24 | 393.95M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
715.20 | 1.05T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
781.54 | 896.82B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
778.01 | 821.68B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
381.32 | 702.31B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
743.57 | 497.30B | 0 | 0 | 0 | 0.00 |
Elevance Health Inc Stock (EELV) Latest News
Invesco's AUM Falls in September: Will Growth Momentum Rebound? - Zacks Investment Research
Are You Looking for a High-Growth Dividend Stock? - Zacks Investment Research
Why Invesco (IVZ) is a Top Growth Stock for the Long-Term - Zacks Investment Research
Emerging Markets Equities ETFs - ETF Database
Precision Trading with Invesco S&p Emerging Markets Low Volatility Etf (EELV) Risk Zones - Stock Traders Daily
Here's Why Invesco (IVZ) is a Strong Value Stock - Zacks Investment Research
ETFs Investing in Haitian International Holdings Limited Stocks - TradingView
Invesco S&P 500 Low Volatility (SPLWL.XC) Stock Price, News, Quote & History - ca.finance.yahoo.com
Invesco Income Allocation Fund Q2 2026 Commentary (Mutual Fund:ALAAX) - Seeking Alpha
Best Performing ETFs: Top Returns at a Glance - TradingKey
Top ETFs: Live Prices, Returns & Trends - tradingkey.com
Best Performing ETFs: Top Returns at a Glance - TradingKey
Invesco (IVZ) Could Be a Great Choice - Zacks Investment Research
Invesco S&P Emerging Markets Low Volatility ETF declares quarterly distribution of $0.4315 - TradingView
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Bond Market Alarm Puts Invesco Low-Volatility Dividend ETF Back in the Spotlight - finance.biggo.com
ETFs Investing in Beijing Enterprises Holdings Limited Stocks - TradingView
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
7 Best Long-Term ETFs to Buy and Hold | Investing - US News Money
6 Best Dividend Index Funds to Buy in 2026 - The Motley Fool
5 Best Emerging Markets ETFs for 2026 and How to Invest - The Motley Fool
Why Does Elevance Health (NYSE:ELV) Matter in S&P 500? - Kalkine Media
Elevance leads UBS health benefits survey as employers brace for higher costs (ELV:NYSE) - Seeking Alpha
Can Centene's Medicare Advantage Strategy Unlock Better Margins? - TradingView
BofA Securities Adjusts Elevance Health Price Target to $480 From $460 - Moomoo
Elevance Health stock gains after reaffirmed 2026 earnings guidance - ad-hoc-news.de
Elevance Health Reaffirms 2026 Earnings and Cost Guidance - The Globe and Mail
ELV (Elevance Health) 5-Year EBITDA Growth Rate : 5.30% (As of Jun. 2026) - GuruFocus
Elevance Health Inc (ELV) Shares Surge 5.0% -- What GF Score of 90 Tells Investors - GuruFocus
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Buy Elevance Health Stock For The Margin It Lost? - trefis.com
Elevance Health reaffirms FY26 EPS guidance, shares rise 5% - scanx.trade
Elevance Health stock gains after 2026 earnings guidance is reaffirmed - ad-hoc-news.de
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation - Benzinga
Why is Elevance Health stock surging today? By Investing.com - Investing.com Nigeria
Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement - TradingKey
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com South Africa
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com Australia
Elevance Health reaffirms 2026 earnings and benefit expense guidance - Investing.com
Elevance Health Gains as Investors Revisit Medicare Advantage Tailwinds - Quiver Quantitative
Elevance Reaffirms 2026 Adjusted Earnings Guidance of at Least $27.00 Per Share - minichart.com.sg
Elevance Health (ELV) Reaffirms 2026 Earnings Guidance of at Lea - GuruFocus
Elevance holds loss ratio guidance above 90% as fall renewals near - Insurance Business
Elevance Health at Wells Fargo conference: growth plan stays on track - Investing.com UK
Elevance Health Inc's Dividend Analysis - GuruFocus
Elevance Health Inc's Dividend Analysis - Yahoo Finance
Form 8K Elevance Health Inc For: 10 September By Investing.com - Investing.com Canada
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com Canada
Should You Buy Elevance Health Stock For The Margin It Lost? - Trefis
Elevance Health Inc Stock (EELV) Financials Data
There is no financial data for Elevance Health Inc (EELV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.20%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):